• ATRX Loss Sensitizes High-Grade Glioma to PDGFR Inhibition

  2026-07-14

  The referenced study demonstrates that ATRX-deficient high-grade glioma cells are particularly vulnerable to receptor tyrosine kinase and PDGFR inhibitors. This finding suggests ATRX status could inform precision therapy and clinical trial design in glioma, with implications for optimizing targeted treatment strategies.

• HOXC8 Suppresses Pyroptosis in NSCLC via Caspase-1 Regulatio

  2026-07-13

  This study reveals that HOXC8, a transcription factor overexpressed in non-small cell lung carcinoma (NSCLC), prevents pyroptotic cell death by repressing caspase-1 expression through HDAC1/2-mediated chromatin regulation. These findings illuminate a novel tumor-promoting mechanism in lung cancer and provide new directions for targeted research on the caspase signaling pathway.

• EZ Cap EGFP mRNA 5-moUTP: Advancing mRNA Delivery and Imagin

  2026-07-13

  EZ Cap™ EGFP mRNA (5-moUTP) redefines mRNA delivery for gene expression with robust, sustained fluorescent protein output and minimal immune activation. Its innovative Cap 1 structure and 5-moUTP modifications streamline both in vitro and in vivo workflows, making it the benchmark choice for translation efficiency, imaging, and immune-evasive reporting.

• Morin: Applied Use-Cases and Protocols for Bench Research

  2026-07-12

  Morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one) stands out as a multi-functional research tool, bridging disease modeling, antioxidant assays, and fluorescent ion detection. This guide translates its molecular mechanisms into stepwise workflows and troubleshooting strategies, enabling reproducible results across diabetes, neuroprotection, and advanced bioanalytical studies.

• EZ Cap™ Human PTEN mRNA (ψUTP): Mechanisms & Benchmarks

  2026-07-10

  EZ Cap™ Human PTEN mRNA (ψUTP) is an in vitro transcribed mRNA engineered for superior stability and translation of the human PTEN tumor suppressor gene. This reagent leverages Cap1 structure and pseudouridine modifications to enhance protein expression while minimizing innate immune activation, providing a robust tool for cancer research and PI3K/Akt pathway inhibition.

• Ibrexafungerp Activity Against Echinocandin-Resistant Candid

  2026-07-09

  This study rigorously evaluates ibrexafungerp's in vitro efficacy against a large cohort of echinocandin-resistant Candida isolates, highlighting its unique profile among antifungals targeting 1,3-β-D-glucan synthase. The findings inform antifungal selection strategies for resistant infections, with implications for translational research and protocol design.

• Capsazepine: Advanced Insights on TRPV1 Antagonism and Apopt

  2026-07-09

  Explore Capsazepine as a potent TRPV1 ion channel antagonist, with an in-depth focus on its mechanistic roles in nociception inhibition and apoptosis sensitization. This article uniquely connects bench research to translational assay design for pain and oncology studies.

• Multi-Omics Reveals ARID1A-Driven Resistance in Melanoma

  2026-07-08

  This study leverages integrative multi-omics to map drug response networks and uncover how ARID1A loss in BRAF-mutant melanoma drives resistance to BRAF/MAPK inhibition. The findings highlight transcriptional rewiring, altered immune evasion, and identify actionable resistance nodes, informing new therapeutic strategies.

• AL-8810: Redefining Prostaglandin F2α Antagonism in Translat

  2026-07-08

  This thought-leadership article explores the evolving landscape of prostaglandin F2α (PGF2α) signaling research, focusing on AL-8810 as a transformative tool for dissecting FP receptor-mediated mechanisms. Integrating mechanistic insights, recent translational breakthroughs, and strategic guidance, we chart a roadmap for investigators leveraging AL-8810 to unravel vascular and endometrial dynamics and their implications for reproductive and vascular biology.

• Transmission Dynamics of Carbapenemase Genes in CREC in Chin

  2026-07-07

  This study characterizes the genetic mechanisms and epidemiology of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong Province. By profiling gene localization, transmission dynamics, and multidrug resistance during the COVID-19 pandemic, it provides critical insights for resistance surveillance and experimental modeling.

• EZ Cap™ Firefly Luciferase mRNA: Precision Reporter Advances

  2026-07-07

  EZ Cap™ Firefly Luciferase mRNA, engineered with a Cap 1 structure and optimized poly(A) tail, dramatically enhances mRNA stability and translation for reporter assays. This product delivers robust, sustained bioluminescent signals suitable for gene regulation and in vivo imaging applications. Its design aligns with modern mRNA delivery strategies, enabling reliable data in translational and molecular biology workflows.

• Firefly Luciferase mRNA (5-moUTP): Applied Workflows & Optim

  2026-07-06

  EZ Cap™ Firefly Luciferase mRNA (5-moUTP) accelerates high-sensitivity reporter assays and gene delivery studies with its Cap 1 structure and 5-moUTP modification, providing enhanced stability and low immunogenicity. This article distills advanced experimental workflows, troubleshooting strategies, and translational insights—bridging bench protocols with next-generation immune-modulatory delivery innovations.

• JZL184: Optimizing Monoacylglycerol Lipase Inhibitor Workflo

  2026-07-06

  JZL184 stands out as a gold-standard monoacylglycerol lipase inhibitor, enabling precise modulation of endocannabinoid signaling in both acute and chronic pain studies. This guide delivers actionable protocols, advanced troubleshooting, and unique translational insights derived from cutting-edge research—empowering next-generation neuropharmacology and behavioral science.

• IRG1-Itaconic Acid Axis Inhibits TBK1-Driven Type I IFN Resp

  2026-07-05

  Chai et al. uncover how the IRG1-itaconic acid axis links cellular metabolism to innate immunity by alkylating TBK1, thereby restraining type I interferon responses. Their development of targeted itaconic acid derivatives (ITA-5 and ITA-9) offers new strategies for modulating hyperinflammatory states.

• Efficient Synthesis of Deuterium-Labeled Degarelix Acetate f

  2026-07-04

  This study introduces a streamlined 13-step protocol for synthesizing deuterium-labeled degarelix acetate, enabling robust internal standards for pharmacokinetic and metabolic research on GnRH receptor antagonists. The method improves yield, reliability, and supports advanced clinical investigations in androgen-related diseases.

17104 records 4/1141 page Previous Next 12345 下5页 Last page